Camrelizumab Biosimilar - Research Grade

Human

PD-1

1.0 - 5.0 mg/ml

Human IgG4

Humanized

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human PD-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Camrelizumab.

Blue ice

The PD-1 checkpoint pathway limits T-cell activity and is a major focus of cancer-immunotherapy research. This research-grade reagent is an unconjugated, non-therapeutic analog of camrelizumab that recognises human PD-1 and supports functional assays. Manufactured to in vivo standards with low endotoxin, it is sold strictly for research use only and supplied in scalable milligram to gram quantities to meet high-throughput demand. Investigators apply it to checkpoint-blockade experiments, T-cell functional readouts, in vitro screening, in vivo immuno-oncology models, and comparative characterisation of biologics, supported by consistent batch-to-batch quality for demanding workflows.

Programmed cell death protein 1, Pdcd1, CD279

Q15116

ICH3002

https://www.imgt.org/mAb-DB/